Ozempic boom collides with America’s eating habits as restaurants shrink portions
Once known for bottomless breadsticks and supersized meals, American chain restaurants are increasingly rethinking their portion sizes. As GLP-1 weight-loss medications like Ozempic, Wegovy and Zepbound go mainstream, restaurants are responding to customers with smaller appetites — and a growing appetite for protein-packed meals. “People on GLP-1s are prioritizing protein because it’s the macronutrient that […]
STAT+: Launch of Wegovy pill looks to be going strong so far
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Today, we see a new synthetic biology startup, backed by Frances Arnold and Bob Langer. Plus, it’s still early, but Novo Nordisk already appears to be having a robust rollout of the Wegovy pill. […]
GLP‐1RAs versus metformin and Parkinson’s risk in type 2 diabetes
Abstract Background Parkinson’s disease (PD) is an increasingly prevalent neurodegenerative condition, particularly among individuals with type 2 diabetes mellitus (T2DM). While prior studies have suggested that GLP-1 receptor agonists (GLP-1RAs) and metformin may confer neuroprotective effects, most were limited by small sample sizes, short follow-up, uncontrolled designs, or lacked direct comparisons between therapies—making their findings […]
Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, Inc. (NASDAQ:VKTX) announced a significant milestone in the development of its obesity drug VK2735. Data published in the peer-reviewed journal Obesity show that the drug achieved a weight loss of 14.7% from baseline after 13 […]
As GLP-1s become more available, some who aren’t overweight may consider using them
As GLP-1 drugs become more available, some people might use them despite not having excess weight.
Gene therapy for weight loss: Can one shot replace lifelong GLP-1 drugs?
US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that aims to trigger long-term weight loss by programming the pancreas to produce more GLP-1 hormone
The Microbiome Doctor: Doctors Were Wrong! The 3 Foods You Should Eat For Perfect Gut Health!
World-leading gut health expert PROFESSOR TIM SPECTOR reveals brand new research around why dementia, depression, and anxiety may start in the gut, how flossing lowers Alzheimer’s risk, and the TOP foods that stop inflammation! Professor Tim Spector is a medical doctor, Professor of Genetic Epidemiology at King’s College London, and co-founder of ZOE, a science-led […]
New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders
This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone. It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.
GLP-1 Therapy May Offer Added Benefit in IBD Beyond Weight Loss
(MedPage Today) — LAS VEGAS — GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their metabolic indication, according to two poster presentations at the Crohn’s & Colitis Congress. In a large…
Engineering Marker‐Free Lettuce Chloroplast Genome to Express Functional Glucagon‐Like Peptide‐1 Receptor Agonists Exenatide and Lixisenatide
Engineering of marker-free lettuce chloroplast genome to express CTB-Exenatide and CTB-Lixisenatide for oral delivery. Upper panel: Chemically synthesised exenatide or lixisenatide require expensive production, purification, refrigeration and invasive delivery methods. Lower panel: Exenatide or lixisenatide fusion with CTB expression in marker-free lettuce facilitates oral delivery and reduces cost by elimination of fermentation or chemical synthesis, […]